STO · SOBI.ST
Swedish Orphan Biovitrum AB
SEK 488.00+SEK 9.80 (+2.05%)
Swedish Orphan Biovitrum AB’s quoted price sits in the upper half of its reported 52-week range, 0.81% below the high.
Loading market information…
STO · HUM.ST · SEK
Stock price, dividends, earnings
Quote as of Oct 27, 2026, 04:29 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SEK. Historical prices are not a forecast.
Humana AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 8.87% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Humana AB (publ)’s forward annual dividend is SEK 1.35 per share, paid annual. The forward yield is 1.9% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Humana AB (publ)’s next earnings report is currently expected on Feb 5, 2027, with estimated earnings per share of SEK 1.08. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Humana AB (publ)’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Humana AB (publ), founded in 2001 and headquartered in Stockholm, Sweden, offers a wide range of individual and family care services across Sweden, Finland, Norway, and Denmark, serving both children and adults. The company's operations are divided into five core segments. The Individual & Family segment delivers comprehensive care and treatment for individuals experiencing psychosocial disorders, mental health conditions, and functional impairments. This includes residential care homes, interim and permanent family care placements, specialized residential solutions, outpatient services, assisted living facilities, specially adapted housing for individuals with functional impairments, and special education schools. The Personal Assistance segment provides dedicated support and assistance to individuals living with functional impairments. The Elderly Care segment specializes in residential care facilities for seniors. Its Finland segment offers individual and family care services for children, young people, and families dealing with psychiatric diagnoses or psychosocial disorders, alongside specialized housing for individuals with functional impairments, and both residential and day care for seniors. Finally, the Norway segment provides individual and family care, personal assistance, and specialized housing for individuals with functional impairments.
Latest available per-share figures in SEK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:41 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Jul 18, 2025 | SEK 0.370.0% vs estimate | SEK 2.51B-1.99% vs estimate |
|---|
| Q1 2025 | Apr 24, 2025 | SEK 1.43+49.74% vs estimate | SEK 2.53B-3.2% vs estimate |
|---|
| Q4 2024 | Feb 6, 2025 | SEK 0.56-50.88% vs estimate | SEK 2.69B+1.23% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 488.00+SEK 9.80 (+2.05%)
Swedish Orphan Biovitrum AB’s quoted price sits in the upper half of its reported 52-week range, 0.81% below the high.
SEK 273.40+SEK 1.50 (+0.55%)
Getinge AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 0.18% below the high.
SEK 341.60+SEK 2.80 (+0.83%)
Sectra AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 0.29% below the high.
SEK 279.50+SEK 2.00 (+0.72%)
Medicover AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 0.89% below the high.
SEK 116.80-SEK 1.30 (-1.1%)
Attendo AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 10.29% below the high.
SEK 183.30-SEK 2.80 (-1.5%)
Ambea AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 3.42% below the high.
SEK 117.00+SEK 1.60 (+1.39%)
AcadeMedia AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 0.51% below the high.
SEK 26.45-SEK 0.50 (-1.86%)
Carasent AB’s quoted price sits in the upper half of its reported 52-week range, 10.19% below the high.
